Law360, New York ( August 22, 2014, 10:16 AM EDT) -- The Patent Trial and Appeal Board issued its first final written decisions on June 20, 2014, in four inter partes reviews of pharmaceutical-related patents. The four decisions effectively invalidated all 58 of the challenged patent claims spread across four patents owned by Merck & Cie and the South Alabama Medical Science Foundation, both of whom previously accused Italian biotech firm Gnosis SpA of infringement. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.